People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Pharma, Other Technology, Other, Fintech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, LLC | — | Pharma | Series A | $12.8M | $396.9M | 2017 |
| Appriss Holdings Inc | — | Other Technology | Series A | $11.0M | $305.1M | 2010 |
| RANE Corp. | — | Other | Series A | $10.5M | $41.6M | 2015 |
| Credit Precision, Inc. | — | Fintech | Seed | $3.2M | $112.7M | 2016 |
Jeff Schwartz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff Schwartz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Miller | 2 | 18 |
| Carl Gordon | 1 | 24 |
| Michael Davis | 1 | 19 |
| Stephen Squinto | 1 | 8 |
| Daniel Lynch | 1 | 7 |
| BOB NYE | 1 | 5 |
| Eric Frank | 1 | 5 |
| Douglas Cobb | 1 | 4 |
| DEVAL PATRICK | 1 | 4 |
| David Lawrence | 1 | 4 |
| NICK READER | 1 | 3 |
| Ted Williams | 1 | 2 |
| Peter Keen | 1 | 2 |
| Rick Simpson | 1 | 2 |
| Jim Swift | 1 | 1 |
| Richard Ross | 1 | 1 |
| Bill Detwiler | 1 | 1 |
| Steve Roycroft | 1 | 1 |
| Jim McWeeney | 1 | 1 |
| Freda Lewis-Hall, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.